| Literature DB >> 30588778 |
Filippo Giacone1, Rossella Cannarella1, Laura M Mongioì1, Angela Alamo1, Rosita A Condorelli1, Aldo E Calogero1, Sandro La Vignera2.
Abstract
During the last decades the study of male infertility and the introduction of the assisted reproductive techniques (ARTs) has allowed to understand that normal sperm parameters do not always predict fertilization. Sperm genetic components could play an important role in the early stages of embryonic development. Based on these acquisitions, several epigenetic investigations have been developed on spermatozoa, with the aim of understanding the multifactorial etiology of male infertility and of showing whether embryonic development may be influenced by sperm epigenetic abnormalities. This article reviews the possible epigenetic modifications of spermatozoa and their effects on male fertility, embryonic development and ART outcome. It focuses mainly on sperm DNA methylation, chromatin remodeling, histone modifications and RNAs.Entities:
Keywords: Epigenomics; Infertility; Infertility, male; Reproductive techniques, assisted
Year: 2018 PMID: 30588778 PMCID: PMC6479088 DOI: 10.5534/wjmh.180071
Source DB: PubMed Journal: World J Mens Health ISSN: 2287-4208 Impact factor: 5.400
Imprinted genes involved in placenta and embryo development and growth in mice [16]
| Process | Imprinted gene |
|---|---|
| Placenta establishing | |
| Nutrient transport capacity and surface area for exchange | |
| Fetal growth |
Cdkn1c: cyclin-dependent kinase inhibitor 1c, Grb10: growth factor bound protein 10, Igf2: insulin-like growth factor 2, Igf2r: insulin-like growth factor 2 receptor, Peg10: paternally expressed 10.
Imprinted genes involved in sperm quality
| Gene | Evidence | Reference |
|---|---|---|
| Increased methylation is associated with decreased semen quality | ||
| Increased methylation in OAT patients compared to controls | ||
| Reduced methylation levels are associated with asthenozoospermia | ||
| Reduced methylation levels are associated with asthenozoospermia | ||
| Abnormal methylation levels are associated with oligozoospermia | ||
| Reduced methylation associates with male infertility | ||
| Increased methylation in patients with abnormal sperm parameters | ||
| Increased methylation associates with male infertility | ||
| Increased methylation associates with male infertility | ||
| Increased methylation associates with male infertility | ||
| Increased methylation associates with oligozoospemia |
CREM: cAMP responsive element modulator, DAZL: deleted in azoospermia-like, FAM50B: family with sequence similarity 50, member B, GNAS: guanidine nucleotide-binding protein, alpha-stimulating activity polypeptide 1, GLT2: gene trap locus 2 (also known as MEG3, maternally expressed gene 3), H19: imprinted maternally expressed non-coding transcript, KCNQ1OT1: KCNQ1-overlapping transcript 1, MEST: mesoderm-specific transcript, mouse, homolog of, RHOX: reproductive homeobox X-linked, SNRPN: small nuclear ribonucleoprotein polypeptide N, ZAC: Zac tumor suppression gene (also known as PLAGL1, pleomorphic adenoma gene-like 1).
Fig. 1Possible influence of H19/IGF2 expression on male fertility. (A) In the paternal allele of healthy fertile men, H19 DMR methylation leads to IGF2 expression. The repression of H19 transcription increase IGF1R expression. Both IGF2 and IGF1R transcripts are involved in sperm capacitation, embryo and placental growth. (B) In infertile men, low H19 DMR methylation rates lead to repression of both IGF2 and IGF1R transcription, thus negatively impacting on sperm capacitation, embryo and placental growth. H19: Imprinted maternally expressed non-coding transcript, IGF2: insulin-like growth, DMR: differentially methylated region, IGF1R: insulin-like growth factor 1 receptor, factor 2.